Business Context and Reporting Period
Company: Evogene Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: November 20, 2025
Reporting Period: Third Quarter ended September 30, 2025
Context: This filing serves to incorporate by reference a press release (Exhibit 99.1) and a conference call slide presentation (Exhibit 99.2) detailing the company's financial results for the quarter.
Key Financial Metrics
The provided text is a cover document for Form 6-K and does not contain specific numerical data. The actual financial statements are located in the attached press release (Exhibit 99.1). Consequently, the following metrics are not available in this text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not disclose specific material changes, year-over-year comparisons, or variance analysis for the third quarter of 2025. Such details are contained within the referenced press release.
Guidance, Outlook, and Risks
Management Commentary: Management held a conference call on November 20, 2025, to discuss the quarterly results. A slide presentation was made available to investors to provide additional business and financial information.
Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, contingencies, or unusual items. These are expected to be detailed in the attached exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q3 2025.
- Examine Exhibit 99.2 (Slide Presentation) for management's strategic outlook and operational highlights.
- Verify the incorporation of GAAP financial statements into active registration statements (Form F-3 and Form S-8) as noted in the filing.
- Confirm the date of the conference call (November 20, 2025) to ensure access to the most recent management commentary.